JF
TARA icon

Jump Financial’s Protara Therapeutics TARA Stock Holding History

Jump Financial’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$776K Buy
203,100
+136,321
+204% +$648K 0.01% 1293
2026
Q1 		$348K Buy
+66,779
New +$395K ﹤0.01% 1416
2021
Q4 		– Sell
-14,500
Closed -$100K – 1708
2021
Q3 		$100K Buy
+14,500
New +$113K 0.01% 971

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Jump Financial's TARA Position: Q2 2026 in Review

Jump Financial increased its Protara Therapeutics (TARA) stake by 204% in Q2 2026, buying an estimated $648K and bringing the position to 203,100 shares worth $776K. The position accounts for 0.01% of the portfolio, ranked #1293.

Jump Financial first reported a position in TARA in Q3 2021 and has held it in 3 quarters since. 119 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • Jump Financial held 203,100 shares of Protara Therapeutics worth $776K as of Q2 2026.
  • Jump Financial bought 136,321 Protara Therapeutics shares in Q2 2026, an estimated $648K.
  • Protara Therapeutics made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1293 holding.
  • Jump Financial first reported a position in Protara Therapeutics in Q3 2021 and has held it in 3 quarters since.
  • 119 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.